Guidance for industry [electronic resource] : contents of a complete submission for the evaluation of proprietary names.
Imprint
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) ; Rockville, MD : Center for Biologics Evaluation and Research (CBER), [2008]
Mode of access: Internet at the FDA Web site. Address as of 3/24/09: http://www.fda.gov/cder/guidance/7935dft.pdf ; current access is available via PURL.
Note
Title from PDF title page (viewed on Mar. 24, 2009).
